Stock listing
HPHAD Stock Price, News, Filings & Events — Heidelberg Pharma Ag
Selected listing: HPHAD · AQUISEU · EUR · GB
This page tracks Heidelberg Pharma Ag's HPHAD:AQUISEU listing on AQUISEU in EUR for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HPHAD:AQUISEU. HPHAD:AQUISEU is the stock-level entry point for investors researching Heidelberg Pharma Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- HPHAD:AQUISEU
- Asset type
- Stock
- Market cap
- $133.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- AQUISEU
- Currency
- EUR
Heidelberg Pharma Ag HPHAD:AQUISEU stock context
This page tracks Heidelberg Pharma Ag's HPHAD:AQUISEU listing on AQUISEU in EUR for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HPHAD:AQUISEU. HPHAD:AQUISEU is the stock-level entry point for investors researching Heidelberg Pharma Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Heidelberg Pharma Ag
Heidelberg Pharma to Present New Clinical Data on Lead ATAC Candidate Pamlectabart Tismanitin at International Myeloma Society Annual Mee...
September 7, 2026
Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
August 26, 2026
Heidelberg Pharma Reports on First Half-Year 2026 and the Positive Course of Business
July 15, 2026
Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2026
June 23, 2026
Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2026
April 29, 2026
Research Heidelberg Pharma Ag
Heidelberg Pharma Ag investor report
Review AI stock analysis and investor report context for HPHAD:AQUISEU.
Heidelberg Pharma Ag company profile
View the public company page for Heidelberg Pharma Ag on 6ix.
Heidelberg Pharma Ag news
Read company news and market updates connected to Heidelberg Pharma Ag.
Heidelberg Pharma Ag investor events
Find investor webinars, events, and replay context for Heidelberg Pharma Ag.
Alternate listings
HPHA:XETR
DE · EUR
Alternate listing for Heidelberg Pharma Ag; the primary context on this page is HPHAD:AQUISEU.
HPHA:GETTEX
DE · EUR
Alternate listing for Heidelberg Pharma Ag; the primary context on this page is HPHAD:AQUISEU.
HPHA:TRADEGATE
DE · EUR
Alternate listing for Heidelberg Pharma Ag; the primary context on this page is HPHAD:AQUISEU.
A11QVV:LSX
DE · EUR
Alternate listing for Heidelberg Pharma Ag; the primary context on this page is HPHAD:AQUISEU.
0QW5:LSE
GB · EUR
Alternate listing for Heidelberg Pharma Ag; the primary context on this page is HPHAD:AQUISEU.
A11QVV:LS
DE · EUR
Alternate listing for Heidelberg Pharma Ag; the primary context on this page is HPHAD:AQUISEU.
HPHA:FWB
DE · EUR
Alternate listing for Heidelberg Pharma Ag; the primary context on this page is HPHAD:AQUISEU.
HPHA:SWB
DE · EUR
Alternate listing for Heidelberg Pharma Ag; the primary context on this page is HPHAD:AQUISEU.
HPHA:DUS
DE · EUR
Alternate listing for Heidelberg Pharma Ag; the primary context on this page is HPHAD:AQUISEU.
HPHA:HAM
DE · EUR
Alternate listing for Heidelberg Pharma Ag; the primary context on this page is HPHAD:AQUISEU.
HPHA:MUN
DE · EUR
Alternate listing for Heidelberg Pharma Ag; the primary context on this page is HPHAD:AQUISEU.
HPHAD:AQUISUK
GB · EUR
Alternate listing for Heidelberg Pharma Ag; the primary context on this page is HPHAD:AQUISEU.